Gut microbiota and probiotics: from theory to practice

DOI: https://doi.org/10.29296/25877305-2023-02-06
Issue: 
2
Year: 
2023

O. Zolnikova, MD; M. Reshetova; Cao XinLu
I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research in recent years has provided much information about the overall composition and function of the gut microbiota. It has been established that the microbiota contributes to maintaining the integrity of the mucosa, providing nutrients, protecting against pathogens, etc. In addition, the interaction between the microbiota and the mucosal immune system is crucial for the formation of adequate immunity. Thus, understanding the human microbiota can be directed towards better diagnosis and rational treatment of many human diseases. The use of probiotics in various nosological forms demonstrate encouraging results. Diseases of the gastroenterological profile and not only often require the appointment of probiotics. The main mechanisms underlying the beneficial effects of probiotics are considered from the standpoint of their pleiotropic action. The choice of multi-strain probiotic preparations is preferable and justified from the point of view of the synergy of its constituent microorganisms, which allows achieving the best effect. The latest generation of probiotics with an innovative protective double shell demonstrate high clinical efficacy due to the preservation of the viability of probiotic microorganisms in the gastrointestinal tract.
Keywords: 
gastroenterology
microbiota
probiotics
Bifidobacteria
Lactobacillus
dietary supplement
Neobiotic

References: 
  1. Aagaard K., Ma J., Antony K.M. et al. The placenta harbors a unique microbiome. Sci Transl Med. 2014; 6 (237): 237ra45. DOI: 10.1126/scitranslmed.3008599
  2. Rodriguez J.M. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Health Dis. 2015; 26: 26050. DOI: 10.3402/mehd.v26.26050
  3. Simpson H.L., Campbell B.J. Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther. 2015; 42 (2): 158–79. DOI: 10.1111/apt.13248
  4. Backhed F., Roswall J., Peng Y. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microb. 2015; 17 (5): 690–703. DOI: 10.1016/j.chom.2015.04.004
  5. De Filippo C., Cavalieri D., Di Paola M. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010; 107 (33): 14691–6. DOI: 10.1073/pnas.1005963107
  6. Avershina E., Storrø O., Øien T. et al. Major fecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. FEMS Microbiol Ecol. 2014; 87 (1): 280–90. DOI: 10.1111/1574-6941.12223
  7. David L.A, Maurice C.F, Carmody R.N, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2012; 505 (7484): 559–63. DOI: 10.1038/nature12820
  8. De Kivit S., Tobin M.C., De Meo M.T. In vitro evaluation of intestinal epithelial TLR activation in preventing food allergic responses. Clin Immunol. 2014; 154 (2): 91–9. DOI: 10.1016/j.clim.2014.07.002
  9. Arumugam M., Raes J., Pelletier E. et al. Enterotypes of the human gut microbiome. Nature. 2011; 473 (7346): 174–80. DOI: 10.1038/nature09944
  10. Dibaise J.K., Young R.J., Vanderhoof J.A. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol. 2006; 4 (1): 11–20. DOI: 10.1016/j.cgh.2005.10.020
  11. Fan X., Sellin J.H. Review article: Small intestinal bacterialovergrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther. 2009; 29 (10): 1069–77. DOI: 10.1111/j.1365-2036.2009.03970.x
  12. Nelis G.F., Vermeeren M.A., Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1990; 99 (4): 1016–20. DOI: 10.1016/0016-5085(90)90621-7
  13. Nucera G., Gabrielli M., Lupascu A. et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2005; 21 (11): 1391–5. DOI: 10.1111/j.1365-2036.2005.02493.x
  14. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, auto immunity and cancer. Physiol Rev. 2011; 91 (1): 151–75. DOI: 10.1152/physrev.00003.2008
  15. Lin H.V., Frassetto A., Kowalik E.J. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One. 2012; 7 (4): e35240. DOI: 10.1371/journal.pone.0035240
  16. Samuelson D.R., Welsh D.A., Shellito J.E. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol. 2015; 6: 1085. DOI: 10.3389/fmicb.2015.01085
  17. Ang Zh., Ding J.L. GPR41 and GPR43 in Obesity and Inflammation–Protective or Causative? Front Immunol. 2016; 7: 28. DOI: 10.3389/fimmu.2016.00028
  18. Kalliomaki M., Salminen S., Poussa T. et al. Probiotics and prevention of atopic disease. 4-year follow-up of a randomized placebo-controlled trial. Lancet. 2003; 361 (9372): 1869–71. DOI: 10.1016/S0140-6736(03)13490-3
  19. Markowiak P., Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017; 9 (9): 1021. DOI: 10.3390/nu9091021
  20. Ивашкин В.Т., Маев И.В., Абдулганиева Д.И. и др. Практические рекомендации Научного сообщества по содействию клиническому изучению микробиома человека (НСОИМ) и Российской гастроэнтерологической ассоциации (РГА) по применению пробиотиков для лечения и профилактики заболеваний гастроэнтерологического профиля у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021; 31 (2): 65–91 [Ivashkin V.T., Mayev I.V., Abdulganieva D.I. et al Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021; 31 (2): 65–91 (in Russ.)]. DOI: 10.22416/1382-4376-2021-31-2-65-91
  21. Everard A., Lazarevic V., Gaïa N. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014; 8 (10): 2116–30. DOI: 10.1038/ismej.2014.45
  22. Evsyutina Y., Komkova I., Zolnikova O. et al. Lung microbiome in healthy and diseased individuals. World J Respirol. 2017; 7 (2): 39–47. DOI: 10.5320/wjr.v7.i2.39
  23. Trompette A., Gollwitzer E., Yadava K. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014; 20 (2): 159–66. DOI: 10.1038/nm.3444
  24. Cabana M.D., McKean M., Caughey A.B. et al. Early Probiotic Supplementation for Eczema and Asthma Pre-vention: A Randomized Controlled Trial. Pediatrics. 2017; 140 (3): e20163000. DOI: 10.1542/peds.2016-3000
  25. Ferreira C., Vieira A., Vinolo M. et al. Review Article The Central Role of the Gut Microbiota in Chronic Inflammatory Diseases. J Immunol Res. 2014; 2014: 689492. DOI: 10.1155/2014/689492
  26. Kalliomaki M., Salminen S., Poussa T. et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007; 119 (4): 1019–21. DOI: 10.1016/j.jaci.2006.12.608.
  27. Hevia A., Milani Ch., López P. et al. Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis. PLoS One. 2016; 11 (2): e0147809. DOI: 10.1371/journal.pone.0147809
  28. Huttenhower C., Gevers D., Kight R. Structure, function and diversity of the healthy human microbiome The Human Microbiome Project Consortium. Nature. 2012; 486 (7402): 207–14. DOI: 10.1038/nature11234
  29. Yoon H., Yoon Y.-S., Kim M.-S. et al. A Probiotic Preparation Duolac-Gold Amelorates Dextran Sulphate Sodium-induced Mouse Colitis by Downregulating the Expression of IL-6. Toxicol Res. 2014; 30 (1): 27–32. DOI: 10.5487/TR.2014.30.1.027
  30. Byun S.J., Lim T.J., Lim Y.J. et al. In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin. Benef Microbes. 2016; 7 (5): 731–7. DOI: 10.3920/BM2016.0029
  31. Kim H.W., Hong R., Choi E.Y. et al. A Probiotic Mixture Regulates T Cell Balance and Reduces Atopic Dermatitis Symptoms in Mice. Front Microbiol. 2018; 9: 2414. DOI: 10.3389/fmicb.2018.02414
  32. Shin J.H., Nam M.H., Lee H. et al. Amelioration of obesity-related characteristics by a probiotic formulation in a high-fat diet-induced obese rat model. Eur J Nutr. 2018; 57 (6): 2081–90. DOI: 10.1007/s00394-017-1481-4
  33. Yeun Y., Lee J. Effect of double-coated probiotic formulation on functional constipation in the elderly: a randomizied, double blind, controlled study. Arch Pharm Res. 2015; 38 (7): 1345–50. DOI: 10.1007/s12272-014-0522-2
  34. Yoon J.S., Sohn W., Lee O.Y. et al. Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Cell Biotech Probiotics Paper Collection. Technical Papers on DUOLAC. J Gastroenterol Hepatol. 2014; 29 (1): 52–9. DOI: 10.1111/jgh.12322
  35. Han K., Wang J., Seo J.G. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. J Gastroenterol. 2017; 52 (4): 432–43. DOI: 10.1007/s00535-016-1224-y
  36. Putra G.N.S., Suraatmaja S., Aryasa I.K.N. Effect of probiotics supplementation on acute diarrhea in infants: a randomized double blind clinical trial. Paediatrica Indonesiana. 2007; 47 (4): 172–8. DOI: 10.14238/pi47.4.2007.172-8
  37. Yang H.J., Min T.K., Lee H.W. et al. Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial. Allergy Asthma Immunol Res. 2014; 6 (3): 208–15. DOI: 10.4168/aair.2014.6.3.208